Drug firms looking to ramp-up production with continuous processes must think beyond the reactor and ensure the technologies used downstream can also manage sustained 24/7 manufacturing. Continuous ...
Downstream Operations Can Relieve the Pressure of Higher Titers and Cell Densities without Undue Disruption Platform manufacturing keeps driving the industrialization of bioprocessing, both upstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback